BIOMAGNETIC TECHNOLOGIES INC
10-C, 1995-04-12
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: HUNT J B TRANSPORT SERVICES INC, DEF 14A, 1995-04-12
Next: AMPAL AMERICAN ISRAEL CORP /NY/, 8-K, 1995-04-12



<PAGE>
 
                THIS DOCUMENT IS A COPY OF THE FORM 10-C FILED
     ON APRIL 10, 1995 PURSUANT TO RULE 201 TEMPORARY HARDSHIP EXEMPTION.

                      SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C.

                                  FORM 10-C

                REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
                         INTERDEALER QUOTATION SYSTEM

                 Filed pursuant to Section 13 or 15(d) of the
                Securities Exchange Act of 1934 and Rule 13a-17
                             or 15d-17 thereunder

                        BIOMAGNETIC TECHNOLOGIES, INC.
                (Exact name of issuer as specified in charter)

                        9727 PACIFIC HEIGHTS BOULEVARD
                          SAN DIEGO, CALIFORNIA 92121
                   (Address of principal executive offices)

                                (619) 453-6300
                          (Issuer's telephone number,
                             including area code)

I. CHANGE IN NUMBER OF SHARES OUTSTANDING

Indicate any change (increase or decrease) of five percent or more in the number
of shares outstanding:

1. Title of security: Common Stock, no par value

2. Number of shares outstanding before the change: 10,027,697
                                                   ----------------

3. Number of shares outstanding after the change: 35,027,697
                                                  ----------------

4. Effective date of change: March 31, 1995

5. Method of change: Specify method (such as merger, acquisition, exchange, 
distribution, stock split, reverse split, acquisition of stock for treasury, 
etc.): Sale of securities in private transaction.

On March 31, 1995, Biomagnetic Technologies Inc. (the "Company") completed the 
sale of 25,000,000 shares of newly issued Common Stock of the Company to
Dassesta International S.A. ("Dassesta"), a foreign investment group, for
$15,000,000. Upon the closing of the investment transaction, Dassesta owns
approximately 71% of the outstanding shares of the Company. The shares issued to
Dassesta have identical rights, preferences and privileges as other shares of
Common Stock of the Company and therefore, the investment transaction by
Dassesta constitutes a change in control of the Company.

II. CHANGE IN NAME OF ISSUER

1. Name prior to change: N/A

2. Name after change: N/A

3. Effective date of charter amendment changing name: N/A

4. Date of shareholder approval of change, if required: N/A




Date: April 10, 1995                /s/ Peter L. Millikin
      --------------                --------------------------------
                                    Peter L. Millikin
                                    Vice President & Controller
                                    (Principal Financial and Accounting Officer)


                                       1


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission